...
首页> 外文期刊>British Journal of Cancer >Heterogeneity in renal cell carcinoma and its impact on prognosis - a flow cytometric study
【24h】

Heterogeneity in renal cell carcinoma and its impact on prognosis - a flow cytometric study

机译:肾细胞癌的异质性及其对预后的影响-流式细胞术研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

In the process of tumour progression genetic instability is the basis for the evolution of tumour cell clones with various genotypic and phenotypic characteristics causing heterogeneity. Renal cell carcinoma has a long prediagnostic growth period, which increases the probability of clonal evolution. We have studied 200 consecutive renal cell carcinomas, addressing the interrelationship between intratumour heterogeneity and clinicopathological factors. DNA ploidy patterns were analysed in multiple samples from each tumour using flow cytometry and compared with clinical stage, tumour invasion, metastatic rate and survival. Eighty-five of 192 evaluable tumours (44%) were homogeneous concerning DNA ploidy (62% diploid, 38% aneuploid). Among 107 heterogeneous tumours a majority (79%) contained aneuploid as well as diploid cell clones. Homogeneously diploid tumours had a lower incidence of local tumour spread compared with tumours with aneuploid cell clones (P < or = 0.001), but the frequency of distant metastasis at time of diagnosis was similar. The presence of aneuploidy in at least one sample from a tumour was a significant adverse prognostic factor (P < 0.001), whereas the degree of heterogeneity had no influence on survival. The frequent heterogeneity demonstrated indicates that multiple samples must be investigated to evaluate properly the malignant character of renal cell carcinoma.
机译:在肿瘤进展过程中,遗传不稳定性是具有各种基因型和表型特征导致异质性的肿瘤细胞克隆进化的基础。肾细胞癌的诊断前期很长,这增加了克隆进化的可能性。我们已经研究了200例连续的肾细胞癌,研究了肿瘤内异质性与临床病理因素之间的相互关系。使用流式细胞仪分析了每个肿瘤的多个样本中的DNA倍性模式,并将其与临床阶段,肿瘤浸润,转移率和存活率进行了比较。涉及DNA倍性的192个可评估肿瘤中有85个(44%)是同质的(62%的二倍体,38%的非整倍体)。在107种异源性肿瘤中,大多数(79%)包含非整倍体和二倍体细胞克隆。与具有非整倍性细胞克隆的肿瘤相比,同质二倍体肿瘤的局部肿瘤扩散发生率较低(P <或= 0.001),但在诊断时远处转移的频率相似。至少一个肿瘤样本中存在非整倍性是重要的不良预后因素(P <0.001),而异质性程度对存活率没有影响。频繁的异质性表明,必须调查多个样本才能正确评估肾细胞癌的恶性特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号